Nermin E. Eleraky
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Molecular Medicine top 10%
Papers in
-
- Advanced Drug Delivery Systems 9
- Advancements in Transdermal Drug Delivery 6
-
- Lipid Membrane Structure and Behavior 3
- RNA Interference and Gene Delivery 2
- Co-authors
- M. Omar (5 shared papers)Ayat Allam (3 shared papers)Mahmoud Elsabahy (2 shared papers)Heba A. Abou‐Taleb (1 shared paper)Ghareb M. Soliman (3 shared papers)Mohamed A. Safwat (4 shared papers)Aml I. Mekkawy (1 shared paper)Mohamed Elnaggar (1 shared paper)
- Journals
- Pharmaceutics (5 papers)AAPS PharmSciTech (2 papers)International Journal of Nanomedicine (2 papers)Journal of Drug Delivery Science and Technology (2 papers)Scientific Reports (1 paper)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Nermin E. Eleraky
18 papers receiving 580 citations
Peers
Comparison fields: 5 of 96
- Pharmaceutical Science 220
- Molecular Medicine 51
- Biomaterials 104
- Microbiology 44
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by Nermin E. Eleraky
This map shows the geographic impact of Nermin E. Eleraky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nermin E. Eleraky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nermin E. Eleraky more than expected).
Fields of papers citing papers by Nermin E. Eleraky
This network shows the impact of papers produced by Nermin E. Eleraky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nermin E. Eleraky. The network helps show where Nermin E. Eleraky may publish in the future.
Co-authors
The 25 scholars most cited alongside Nermin E. Eleraky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 241 | |
| 2 | 2021 | 74 | |
| 3 | 2020 | 68 | |
| 4 | 2022 | 38 | |
| 5 | 2020 | 38 | |
| 6 | 2020 | 24 | |
| 7 | 2022 | 21 | |
| 8 | 2022 | 21 | |
| 9 | 2011 | 13 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 6 | |
| 15 | Hydrophobic Ion-Pairing of Low Molecular Weight Heparin with Cetyltrimethylammonium Bromide | 2015 | 5 |
| 16 | 2024 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2017 | 2 | |
| 19 | 2025 | 0 |
About Nermin E. Eleraky
Nermin E. Eleraky is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Public Health, Environmental and Occupational Health and Organic Chemistry, having authored 19 papers that have together received 593 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (9 papers), Advancements in Transdermal Drug Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Lipid Membrane Structure and Behavior (3 papers), Ocular Surface and Contact Lens (3 papers), Nanoplatforms for cancer theranostics (2 papers), Analytical Chemistry and Chromatography (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (220 citations), Molecular Medicine (51 citations), Biomaterials (104 citations), Microbiology (44 citations) and Applied Microbiology and Biotechnology (10 citations). Nermin E. Eleraky has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include M. Omar, Ayat Allam, Mahmoud Elsabahy, Heba A. Abou‐Taleb, Ghareb M. Soliman, Mohamed A. Safwat, Aml I. Mekkawy, Mohamed Elnaggar, Giovanni M. Pauletti and Mohamed A. Attia. Their work appears in journals such as Pharmaceutics, AAPS PharmSciTech, International Journal of Nanomedicine, Journal of Drug Delivery Science and Technology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.